Sokovnina Ia M, Pestina T I, Tentsova I A, Ploshch O P, Votrin I I
Vopr Med Khim. 1985 Mar-Apr;31(2):76-9.
Activity of purine nucleoside phosphorylase (EC 2.4.2.1) was estimated in thrombocytes of donors and of patients with various hematological diseases. The enzymatic activity was decreased in chronic lymphoid leukosis chronic myeloleukemia, chronic myeloleukemia and blast transformation, acute lymphoblast and myeloblast leukemia, myeloma. Dissimilar level of purine nucleoside phosphorylase activity was found in non-Hodgkin disease. The activity was only slightly increased in Waldenström's macroglobulinemia; it was similar to normal level in hypoplastic and autoimmune hemolytic anemias. A decrease in the enzymatic activity was observed in thrombocytes of the patients with hereditary forms of hemorrhagic diatheses (hemophilia A, Willebrand disease). Normal level of the enzymatic activity was noted in Glanzmann thrombasthenia.
在供体以及患有各种血液疾病的患者的血小板中,对嘌呤核苷磷酸化酶(EC 2.4.2.1)的活性进行了评估。在慢性淋巴细胞白血病、慢性粒细胞白血病、慢性粒细胞白血病急变期、急性淋巴细胞白血病和急性粒细胞白血病、骨髓瘤中,酶活性降低。在非霍奇金病中发现嘌呤核苷磷酸化酶活性水平不同。在华氏巨球蛋白血症中,该活性仅略有增加;在再生障碍性贫血和自身免疫性溶血性贫血中,其活性与正常水平相似。在患有遗传性出血性疾病(甲型血友病、血管性血友病)的患者的血小板中,观察到酶活性降低。在血小板无力症中,酶活性水平正常。